David S. Mathai1,2
, Jill O. Robinson1, Kevin Wagner2, Logan Neitzke-Spruill1, Dayan Berrones2, Jacey L. Anderberg2,3, Renee M. Frederick2,4, Vanessa Zavala Cruz2, Josselyn S. Munoz2, Latin American Trans-Ancestry INitiative for O.C.D. genomics (LATINO)†,, Brazilian Obsessive-Compulsive Spectrum Disorder Working Group (GTTOC)‡,, Carolyn I. Rodriguez5, Lynnette A. Averill1,2,6, James J. Crowley7, Eric A. Storch2
, Amy L. McGuire1
DOI: 10.47626/1516-4446-2025-4316
Epub: July 28 2026
1Ethical Legal Implications of Psychedelics in Society Program, Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX, USA
2Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA
3Department of Psychology, University of Nebraska-Lincoln, Lincoln, NE, USA
4Department of Psychology, University of Houston, Houston, TX, USA
5Psychiatry & Behavioral Sciences, Stanford University School of Medicine, Palo Alto, CA, USA
6The Menninger Clinic, Houston, TX, USA
7Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
David S. Mathai, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. E-mail: d.s.mathai@gmail.com